Skip to content
Screener

Polaryx Therapeutics, Inc. PLYX Q4 2025 Annual earnings

Reported March 24, 2026

EPS-$0.13Miss by $0.11
EPS estimate-$0.02

Next report

Date not yet announced

Financials

Q4 2025

Balance sheet

See full
Cash & equivalents$5.1M+11.3%
Total equity$4.6M-3.1%
Total assets$5.2M+3.4%

Versus estimates

Diluted EPS

Q2 2026-$0.03Beat by $0.01Q1 2026-$0.05Miss by $0.03
Q4 2025-$0.13Miss by $0.11
Q3 2025-$0.03

FAQ

When did Polaryx Therapeutics, Inc. report Q4 2025 earnings?
Polaryx Therapeutics, Inc. (PLYX) reported Q4 2025 earnings on March 24, 2026.
What were Polaryx Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Polaryx Therapeutics, Inc. reported eps of $-0.13 for Q4 2025.
Did Polaryx Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.02 by $0.11.
Where can I find Polaryx Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 10-K periodic report (0001213900-26-033064) directly on SEC EDGAR. The filing index links above go to sec.gov.